Fabroa, Keziah .

HRN: 28-69-60  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/15/2026
03/22/2026
IV
26.2
Q6h
ATP
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: